Ministry of Foreign Affairs of Japan Medical Visa Guarantee Agency No. B-66
Fukuoka Prefecture, Japan Travel service No. 35
Japanese Registration Support Organization No. 19-000303
Japan Medical Equipment Sales and Leasing
Medical Supporter
Accompanied with heart, medical care support in Japan
Cancer Stem Cell Vaccine Therapy
Advanced clinic
【Stock type】Cancer Stem Cell Vaccine
Combined with six activated immune cell therapies to enhance the therapeutic effect
cancer stem cell
The cells that produce cancer cells are called cancer stem cells. Stem cells exist in very small amounts in cancer tissues, and have the characteristics of self-replication and the ability to become the foundation of surrounding cancer cells. Cancer stem cells were first discovered in the blood of patients with acute myeloid leukemia by a Canadian research team in 1997, and have been found in breast cancer, brain tumor, colorectal cancer, esophageal cancer, pancreatic cancer, liver cancer, etc. .
Traditional cancer treatment uses surgery, chemotherapy, and radiotherapy, but according to the information provided by the hospital, it is also pointed out that after such treatment, the remaining cancer stem cells can continue to produce cancer cells, and these cells will gradually respond to chemotherapy or chemotherapy. It is radiation resistance that is the so-called treatment failure.
Combined with activation of six kinds of immune cell therapy
This technology is the simultaneous activation of six types of cells including γδT cells, NK cells, NKT cells, killer T cells (CTL), dendritic cells, and helper T cells. The ability to identify cancer cells, the overall proliferation of six types of cells from 10 to 20 million cells to 2 to 5 billion, and then inject them into the patient's body to recreate the body's immune function, improve immunity, and strengthen the attack on cancer cells power to achieve a higher therapeutic effect.
Except for some leukemias and some malignant lymphomas, almost all cancers can be treated. It also has a good effect on difficult-to-treat cancer or advanced cancer. Even in the face of metastatic or recurrent cancer that is difficult to treat through surgery, anticancer drugs, and radiation therapy, it is possible to achieve the effect of shrinking cancer lesions, inhibiting the development of cancer, and even completely disappearing cancer cells after treatment with this therapy. It is also very effective in the prevention of cancer recurrence and metastasis.
In addition, " NKT cells" have a characteristic of being highly resistant to anticancer agents, steroids, and radiation. It is very helpful to reduce side effects and improve the quality of life by using anticancer drugs, radiation therapy, and other treatment methods before and after surgery.
Since 6 types of
Comprehensive treatment with "immune cells"
So there are high expectations for the treatment effect.
How 6 Combination Immunotherapies Compare to Other Immunotherapies
◎Therapeutic Features
1. The 6 compound immunotherapies developed with unique technology have great expectations compared to other cell therapies that only have NK cells or dendritic cells alone.
2. The side effects are very small and will not cause any burden on the spirit and body. Because the patient's own immune cells are used for treatment, there are almost no side effects.
3. If it is used together with other cancer treatment methods, better therapeutic effect can be expected. If it is used together with radiation therapy before and after surgery and anticancer drugs, it can reduce the side effects of anticancer drugs and improve the quality of life.
4. It can treat a variety of complex and metastatic cancers. Except for some leukemias and some malignant lymphomas, it is used for almost all cancers.
5. It can be used to prevent the recurrence and metastasis of cancer. It is also used to destroy cancer cells left in the body after surgery.
6. Since the treatment is carried out through blood drawing and drip, no hospitalization is required. Because the method of going to the hospital regularly for treatment is adopted, the patient can be treated without changing the current pace of life.
◎Treatment process
plasma
Lymphocyte layer
Separation fluid
red blood cells, white blood cells
Blood collection 30ml
Lymphocyte isolated
Lymphocytes before culture
Activation and proliferation of immune cells
CO2 permeation bag
Therapeutic IV
γδT cells, NK cells, NKT cells, killer T cells, dendritic cells, helper T cellsActivation‧proliferation
drip injection
cultured for three weeks
WT1/CSC specific antigen
◎Treatment plan
basic treatment process
A course of treatment takes about 3~5 months
examine
First treatment
Round two
third time
fourth time
Fifth time
sixth time
blood collection
blood collection
blood collection
blood collection
blood collection
blood collection
3 weeks
2~3 weeks
2~3 weeks
2~3 weeks
2~3 weeks
2~3 weeks
drip
drip
drip
drip
drip
drip
examine
*Healthy people can inject cells every 3 to 6 months when they are carrying out six kinds of compound immune BASIC. You can adjust the time according to your own schedule at any time (because the cell culture cycle is 3 weeks, please inform us 3 weeks before you want to invest).
6 kinds of compound immunotherapy BASIC
Storage-style five-kind compound cell as a preventive therapy for cancer prevention and cancer recurrence
-
The 6 compound immunotherapies developed with unique technology are not just for a single NK cell or dendritic cell, but a more comprehensive cell therapy.
-
Can effectively prevent cancer and recurrence.
-
Effectively delay aging and play a role in strengthening the body.
-
It has a great improvement effect on infectious diseases such as herpes, which are helpless to medicines, and can greatly reduce BCancer of liver and liver C patients due to aging or weakening of constitution.
-
Since the treatment is done through blood draws and drips, no hospitalization is required. Because the method of going to the hospital for treatment on a regular basis is adopted, patients can be treated without changing their current life rules.
◎ Physician introduction
experience
1970 Tokyo University Graduate School of Medicine
1971 University of Mississippi School of Medicine (International Students, Ministry of Education)
Clinical Research Fellow, McGill University, Montreal, Canada
Clinical Research Fellow, Royal Victoria Hospital
Associate Professor of Internal Medicine and Immunology, University of Oregon
Instructor/Associate Professor of Internal Science, Santa Mariana University School of Medicine